Global Biochips Market Size: $14,303 Million in 2024, CAGR of 11.8%

Global biochips market was valued at $14,303 million in 2024 and is growing at a CAGR of 11.8% during the forecast period (2025-2035). Strategic public investments in advanced bio-device and biochip research are playing a crucial role in strengthening national innovation ecosystems. These initiatives enhance local R&D capabilities, improve global competitiveness, and accelerate the commercialization of next-generation biochip technologies. As a result, such investments directly support the growth of the global biochips market by expanding research infrastructure, encouraging innovation, and enabling faster translation of laboratory advancements into commercial and clinical applications.

Browse the full report description of “Biochips Market Size, Share & Trends Analysis Report, By Type (DNA Chips, Lab-on-a-Chip, Protein Chips, and Others), By Fabrication Technology (Microarrays and Microfluidics), By End-User (Hospitals and Diagnostic Centers, Academic and Research Institutes, and Biotechnology and Pharmaceutical Companies) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/biochips-market

In line with this trend, governments are increasingly funding dedicated biochip research facilities to support cross-sector applications in healthcare, agriculture, energy, and environmental solutions. For instance, in December 2024, Israel invested over $30 million to establish its first research laboratory for bio-devices and biochips, in collaboration with Israel Aerospace Industries and Beckermus Technologies. This initiative, spearheaded by the Israel Innovation Authority with a total funding of $31 million, aims to enhance advancements in medicine, agriculture, energy, and environmental solutions. The lab will provide unique R&D services, fostering competition among Israeli researchers and companies on a global scale and substantially contributing to the local biotechnology sector. Biochips allow for simultaneous biological analyses, improving the speed and precision of medical tests, reducing costs, and aiding in genetic disease diagnosis and drug development.

Key Biochips Innovators Driving Transformation

The key players in the Biochips market include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corp., Illumina, Inc., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.

• In May 2024, Boston Micro Fabrication (BMF) launched BMF Biotechnology to enhance the application of 3D BioChips in pharmaceutical research. These innovative organ-on-a-chip platforms facilitate the cultivation of large-scale tissues in vitro, accelerating drug and cosmetic development. Renowned for its micro-printing technology, BMF provides high-resolution solutions across medical devices, electronics, and life sciences. The BioChips enable comprehensive studying of biological mechanisms, drug safety, and patient response predictions, featuring a vascular-mimetic network for efficient nutrient and waste exchange. This advances testing precision over conventional 2D cultures and animal models.

Market Coverage

• The market number available for – 2024-2035
• Base year- 2024
• Forecast period- 2025-2035
• Segment Covered-
  • By Type
  • Fabrication Technology
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corp., Illumina, Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biochips Market Report Segment

By Type

• DNA Chips
• Lab-on-a-Chip
• Protein Chips
• Others

By Fabrication Technology

• Microarrays
• Microfluidics

By End User

• Hospitals and Diagnostic Centers
• Academic and Research Institutes
• Biotechnology and Pharmaceutical Companies

Global Biochips Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biochips-market